Replaces Prod. #: ALX-550-204
Potent dopamine re-uptake inhibitor.
Product Details
| Formula: | C19H25NS . C4H4O4 |
| |
| MW: | 415.6 |
| |
| CAS: | 112726-66-6 |
| |
| Purity: | ≥98% (HPLC) |
| |
| Identity: | Determined by MS. |
| |
| Appearance: | Off-white solid. |
| |
| Solubility: | Soluble in 100% ethanol. |
| |
| Shipping: | Ambient Temperature |
| |
| Long Term Storage: | +4°C |
| |
| Use/Stability: | Store, as supplied, at 0-4°C for up to 1 year. Store solutions at -20°C for up to 3 months. |
| |
| Regulatory Status: | RUO - Research Use Only |
| |
Please mouse over
Product Literature References
Further studies of the structure-activity relationships of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine. Synthesis and evaluation of 1-(2-benzo[b]thienyl)-N,N-dialkylcyclohexylamines at dopamine uptake and phencyclidine binding sites: X. He, et al.; J. Med. Chem.
36, 4075 (1993),
Abstract;
Synthesis and biological evaluation of 1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine homologues at dopamine-uptake and phencyclidine- and sigma-binding sites: X. He, et al.; J. Med. Chem.
26, 1188 (1993),
Abstract;
Differential interaction of phencyclidine-like drugs with the dopamine uptake complex in vivo: T. Maurice et al.; J. Neurochem.
56, 553 (1991),
Abstract;
The phencyclidine (PCP) analog N-[1-(2-benzo(B)thiophenyl) cyclohexyl]piperidine shares cocaine-like but not other characteristic behavioral effects with PCP, ketamine and MK-801: W. Koek et al.; J. Pharmacol. Exp. Ther.
250, 1019 (1989),
Abstract;
[3H]N-[1-(2-benzo(b)thiophenyl)cyclohexyl]piperidine ([3H]BTCP): a new phencyclidine analog selective for the dopamine uptake complex: J. Vignon et al.; Eur. J. Pharmacol.
148, 427 (1988),
Abstract;
